Swiss COVID-19 hospital surveillance: an in-depth analysis of the factors associated with hospital readmission dynamics in community-acquired COVID-19 cases
Laure Vancauwenberghe(University of Geneva), Janne Estill(University of Geneva), Danielle Vuichard‐Gysin, Anne Iten(University Hospital of Geneva), M. Roelens(BIOASTER), Carlo Balmelli, Olivia Keiser(University of Geneva), Peter W. Schreiber(University Hospital of Zurich), Rami Sommerstein(University of Bern), Nicolas Troillet(Hôpital du Valais), Valentin Buchter(Federal Office of Public Health), Sarah Tschudin‐Sutter(University of Basel), Michael Buettcher(University of Lucerne), Marie-Céline Zanella(University of Geneva), Kene David Nwosu(University of Geneva), Philipp Jent(University of Bern), Jonathan Sobel(University Hospital of Geneva), Laura Urbini(University of Geneva), Domenica Flury
Cited by 0
Related Papers
Cancer Risk in the Swiss HIV Cohort Study: Associations With Immunodeficiency, Smoking, and Highly Active Antiretroviral Therapy
|JNCI Journal of the National Cancer Institute|2005|857
European Society of Clinical Microbiology and Infectious Diseases: 2021 update on the treatment guidance document for Clostridioides difficile infection in adults
|Clinical Microbiology and Infection|2021|615
Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study
|British Journal of Cancer|2010|301
Coronavirus Disease 2019 (COVID‐19): Do Angiotensin‐Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
|Journal of the American Heart Association|2020|279